753 (Temozolomide 100 mg)

Pill with imprint 753 is Pink & White, Capsule-shape and has been identified as Temozolomide 100 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 753

Temozolomide

Imprint: 753
Strength: 100 mg
Color: Pink & White
Size: 16.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Alkylating agents
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: Zydus Pharmaceuticals (USA) Inc.
Manufacturer: Cadila Healthcare Limited
National Drug Code (NDC): 68382-0753
Inactive Ingredients: lactose anhydrous, sodium starch glycolate type B potato, tartaric acid, stearic acid, butyl alcohol, alcohol, ferrosoferric oxide, isopropyl alcohol, potassium hydroxide, propylene glycol, shellac, ammonia, water, gelatin, titanium dioxide, sodium lauryl sulfate, FD&C Red No. 3, D&C Yellow No. 10, silicon dioxide
Note: Inactive ingredients may vary.